Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiology ; 130(4): 211-20, 2015.
Article in English | MEDLINE | ID: mdl-25791172

ABSTRACT

When subjected to pressure overload, the ventricular myocardium shifts from fatty acids to glucose as its main source for energy provision and frequently increases its mass. Here, we review the evidence in support of the concept that metabolic remodeling, measured as an increased myocardial glucose uptake using dynamic positron emission tomography (PET) with the glucose analogue 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG), precedes the onset of left ventricular hypertrophy (LVH) and heart failure. Consistent with this, early intervention with propranolol, which attenuates glucose uptake, prevents the maladaptive metabolic response and preserves cardiac function in vivo. We also review ex vivo studies suggesting a link between dysregulated myocardial glucose metabolism, intracellular accumulation of glucose 6-phosphate (G6P) and contractile dysfunction of the heart. G6P levels correlate with activation of mTOR (mechanistic target of rapamycin) and endoplasmic reticulum stress. This sequence of events could be prevented by pretreatment with rapamycin (mTOR inhibition) or metformin (enzyme 5'-AMP-activated protein kinase activation). In conclusion, we propose that metabolic imaging with FDG PET may provide a novel approach to guide the treatment of patients with hypertension-induced LVH.


Subject(s)
3-O-Methylglucose/analogs & derivatives , Glucose-6-Phosphate/metabolism , Hypertrophy, Left Ventricular/physiopathology , Myocardium/metabolism , TOR Serine-Threonine Kinases/metabolism , 3-O-Methylglucose/metabolism , Animals , Disease Models, Animal , Endoplasmic Reticulum Stress/physiology , Fatty Acids/metabolism , Heart Failure/physiopathology , Heart Ventricles/metabolism , Humans , Hypertension/complications , Hypertrophy, Left Ventricular/therapy , Hypoglycemic Agents/therapeutic use , Metformin/therapeutic use , Mice , Positron-Emission Tomography , Rats , Sirolimus/therapeutic use , Ventricular Function, Left
2.
J Med Entomol ; 49(3): 672-7, 2012 May.
Article in English | MEDLINE | ID: mdl-22679876

ABSTRACT

The objective of this study was to investigate the effects of three fragrance fixatives, Glucam P-20, Vanillin, and Fixolide, on the mosquito repellent property of citronella oil lotions. In the current study, two formulae (A and B) of oil-in-water citronella oil lotions were formulated using different ingredients (emulsifiers [Cremophors or Emulwax], stiffening agents, and emollients). Citronella oil was used at 10% wt:wt. The weight ratios tested between citronella oil and each fixative were 1:0.25, 1:0.5, and 1:1. Overall, 20 formulations, including one with no fixatives for both A and B, were produced, A1-A10 and B1-B10. The repellent activities of these 20 lotions against Aedes aegypti (L.) were tested using a human-bait technique. The types and concentrations of fixatives as well as the compositions of the formulations did affect the protection time of the citronella oil lotions. The lotion containing Emulwax and 5% vanillin (B6) was the most effective repellent. It provided the longest protection time of 4.8 h, which exceeded the minimum requirement of 2 h set by the National Institute of Health, Thailand. The shortest protection time (1 h) was observed in the lotion containing Emulwax and 2.5% Glucam P-20 (B2). It could be concluded that the tested fixatives affected the repellent activity of the citronella oil lotions.


Subject(s)
Benzaldehydes , Culicidae , Insect Repellents , Plant Oils , 3-O-Methylglucose/analogs & derivatives , Animals , Drug Synergism , Humans , Tetrahydronaphthalenes
3.
J Neurol Neurosurg Psychiatry ; 59(4): 427-31, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7561924

ABSTRACT

Positron emission tomography with [18F]-2-fluoro-2-deoxy-D-glucose ([18F]FDG) has been used to assess the pattern of cerebral metabolism in different types of epilepsies. However, PET with [18F]FDG has never been used to evaluate drug naive patients with cryptogenic temporal lobe epilepsy, in whom the mechanism of origin and diffusion of the epileptic discharge may differ from that underlying other epilepsies. In a group of patients with cryptogenic temporal lobe epilepsy, never treated with antiepileptic drugs, evidence has been found of significant interictal glucose hypermetabolism in a bilateral neural network including the temporal lobes, thalami, basal ganglia, and cingular cortices. The metabolism in these areas and frontal lateral cortex enables the correct classification of all patients with temporal lobe epilepsy and controls by discriminant function analysis. Other cortical areas--namely, frontal basal and lateral, temporal mesial, and cerebellar cortices--had bilateral increases of glucose metabolism ranging from 10 to 15% of normal controls, although lacking stringent statistical significance. This metabolic pattern could represent a pathophysiological state of hyperactivity predisposing to epileptic discharge generation or diffusion, or else a network of inhibitory circuits activated to prevent the diffusion of the epileptic discharge.


Subject(s)
3-O-Methylglucose/analogs & derivatives , Brain/metabolism , Epilepsy, Temporal Lobe/metabolism , Glucose/metabolism , Nerve Net/metabolism , Adolescent , Adult , Analysis of Variance , Brain/diagnostic imaging , Epilepsy, Temporal Lobe/diagnostic imaging , Female , Fluorine Radioisotopes , Humans , Male , Methylglucosides , Middle Aged , Nerve Net/diagnostic imaging , Tomography, Emission-Computed
4.
Int J Lepr Other Mycobact Dis ; 60(4): 575-9, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1299713

ABSTRACT

The results of studying the microtiter particle agglutination (MPA) test for detecting anti-Mycobacterium leprae antibodies in blood sera are presented. The serodiagnostic test is based on the agglutination of colored polyacrolein latex microparticles (PAMP) conjugated with 3,6-di-O-methyl-D-glucose (DMG). Sera from 45 leprosy patients (LL, BL), 34 leprosy contacts, and 148 control subjects were investigated by the MPA test. A correlation between the anti-M. leprae antibodies and the bacterial load was found. In many long-treated leprosy patients increased titers of anti-DMG antibodies were observed, which might be due to specific polyneuritis in them. Four contacts of leprosy patients were also positive in the MPA test. "Nonleprosy" sera did not react in the test. The method proposed proved to be of high specificity and sensitivity for the serological diagnosis of leprosy. The rapidity, simplicity, and visual assessment of the results allow the method to be used in the field for epidemiological studies of leprosy contacts and the general population in leprosy-endemic areas.


Subject(s)
3-O-Methylglucose/analogs & derivatives , Agglutination Tests/methods , Antigens, Bacterial , Leprosy/diagnosis , Acrolein , Antibodies, Bacterial/analysis , Enzyme-Linked Immunosorbent Assay , Glycolipids/immunology , Humans , Immunoglobulin G/analysis , Methylglucosides , Microspheres , Mycobacterium leprae/immunology , Polymers , Reagent Kits, Diagnostic
SELECTION OF CITATIONS
SEARCH DETAIL
...